WHO Warns On False Medicines "Ravaging World Markets"

11 November 1996

Along with a French humanitarian group, the World Health Organization has sent out an alarm warning about the spread of "huge quantities of false medicines in the world markets each year, especially in the markets of developing countries, according to the Xinhua news agency.

The French daily Le Monde quoted WHO officials and humanitarian groups as saying that in Africa, 60% of the medicines and nutritional drinks being sold could be false medicines bearing the trade marks of European and North American producers.

In Nigeria, it is alleged by the WHO officials, 109 children died in 1990 after drinking syrup which was actually motor anti-freeze, and in Bangladesh, nearly 250 children died in 1993 for similar reasons. The French Medecins sans Frontiers group said that its staff discovered in 1995 that false vaccines against meningitis were circulating in Niger, West Africa (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight